Pulmonary damage after hospitalization for acute COVID-19, an exploratory prospective cohort study.

Pulmonary damage after hospitalization for acute COVID-19, an exploratory prospective cohort study. - Pulmonary damage after acute COVID-19.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54891

Enrollment

150

Registered

2020-07-02

Start date

2020-07-14

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients eligible for post-COVID-19 care program 2. Written informed consent from patient or legal representative 3. CT during admission with CO-RADS >

Exclusion criteria

Exclusion criteria: 1. Age

Design outcomes

Primary

Measure	Time frame
The primary objective of the study is to determine types and prevalence of residual pulmonary damage after hospital admission for acute COVID-19 at 3 and 12 months follow-up.	—

Secondary

Measure	Time frame
1. To determine clinical and imaging parameters in the acute phase of COVID-19 that may predict lung damage (including pulmonary perfusion abnormalities) at 3 and 12 month follow-up 2. To determine which types of damage remain after 1 year 3. To correlate the amount and type of pulmonary damage with the clinical parameters 3 and 12 month follow-up 4. To determine the value of d-dimer levels and YEARS criteria at 3 months for prediction of pulmonary perfusion abnormalities	—

Measure

Time frame

1. To determine clinical and imaging parameters in the acute phase of COVID-19 that may predict lung damage (including pulmonary perfusion abnormalities) at 3 and 12 month follow-up 2. To determine which types of damage remain after 1 year 3. To correlate the amount and type of pulmonary damage with the clinical parameters 3 and 12 month follow-up 4. To determine the value of d-dimer levels and YEARS criteria at 3 months for prediction of pulmonary perfusion abnormalities

—

Countries

Netherlands

Outcome results